Immunovant, Inc. (IMVT) stock chart

IMVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31

Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30

$35.05−1.99 (-5.37%)

Close on Nov 12, 2026Market cap $7.24BP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?